Navigation Links
Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program
Date:11/18/2008

HERNDON, Va., Nov. 18 /PRNewswire-USNewswire/ -- Cascades Technologies, Inc. (CTi), a federal government professional consulting firm, announced that it was chosen to provide a variety of web-based services in support of DoD's Blast Injury Research Program. Working closely with prime contractor Science Applications International Corporation (NYSE: SAI) and the Blast Injury Research Program Coordinating Office (PCO) at the U.S. Army Medical Research and Materiel Command (USAMRMC), CTi will support Phase 3 of the project after having successfully supported the first two phases of the program.

Established in July 2006 by DoD Directive 6025.21E (Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries), the purpose of the program is to coordinate and manage relevant DoD research efforts and programs for the prevention, mitigation, and treatment of blast injuries. Leveraging research and expertise from both within and outside the DoD, the Blast Injury Research Program is focused on filling knowledge gaps in three key topic areas--Injury Prevention, Acute Treatment, and Reset (activities necessary to return injured war fighters to duty readiness or ensuring a healthy return to civilian life).

"The debt we owe our brave war fighters for their sacrifices is immeasurable, therefore, we are deeply honored to do our part to help ensure everything is done to try to minimize the loss of life, improve the quality of life and reduce the long term impact of blast-related traumas faced by our men and women in uniform," said Alfredo Casta, President and CEO of Cascades Technologies, Inc. SAIC senior vice president and business unit general manager Robert McCord added, "Nothing we do is more important than the service we provide to help ensure our military personnel can be successful and safe."

Among some of the Program's early accomplishments include advanced simulation of blast-induced brain injuries to improve the design of personal protective equipment, development of a prototype agent using freeze-dried platelets that improves clotting time and clot strength to facilitate wound-healing, procedures and products that may lengthen amputated fingers and restore function to blast-injured limbs and faces. Dozens of other accomplishments and medical breakthroughs are listed on the Program's new website.

Under Phase 3, CTi will design, develop and maintain databases for collecting, managing and analyzing blast injury research program data from summaries of ongoing clinical research to program budget data and much more. CTi will also manage the content for an informational website to disseminate blast injury research program information to the public, DoD leadership and researchers, to include research publications, upcoming events, and news items. Additionally, CTi will develop and maintain a web-based, password-protected program management system for collecting and sharing information among DoD blast injury researchers.

CTi's innovative Puerto Rico Applications Development And Support center (PRADAS) will develop the bulk of the software working closely with CTi's Headquarters Program Management Office, SAIC, and the staff at the Blast Injury Research PCO. The CTi team will apply CMMI Level 2 best practices in support of this effort.

Cascades Technologies, Inc. (CTi), is a customer-focused professional consulting firm committed to acting as a reliable advisor to its clients; driving efficiency and productivity, resulting in improved services. From diagnosis to solutions, CTi identifies areas of improvement and helps deliver results, including customized technology applications specific to the client's needs. An 8(a) certified, Hispanic-owned business, CTi's primary customers are civilian agencies within the Federal government and various health related entities. In addition to its Herndon, VA headquarters, CTi has established offices in Washington, DC, and San Juan, Puerto Rico.

To learn more about Cascades Technologies, Inc. (CTi), call 703.793.7222 or visit www.cascadestech.com


'/>"/>
SOURCE Cascades Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GSA Selects Cascades Technologies, Inc. (CTi) to Support USA.gov
2. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
7. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
8. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
9. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
10. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
11. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... NextSteps 2017, NetDimensions’ annual global user ... this May on the following dates: , ?    London, UK from May 10-11, ?    New ... and Performance Institute will be the opening keynote speaker at the NextSteps ...
(Date:4/26/2017)... Pa. , April 26, 2017  Genisphere ... delivery platform, has signed a collaborative and sponsored ... Dr. Silvia Muro . The overall goal ... and pharmacodynamics of various 3DNA designs and formulations ... involve targeting diseases of the vasculature as well ...
(Date:4/25/2017)... ... April 25, 2017 , ... Franz Inc ., ... development tools, and market leader for Semantic Graph Database technology, today ... within the most effective system for developing and deploying applications to solve the ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
Breaking Biology Technology:
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
Breaking Biology News(10 mins):